Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug discovery
<h4>Background</h4>Early detection of drug-induced liver injury (DILI) during drug development is crucial for reducing drug attrition and ensuring the safety of patients. A versatile, biologically interpretable, and dose-dependent screening approach is therefore needed to inform …
Read PDF